Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Behçet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria.
FDA Accepts Biologics License Application For ZINBRYTA (Daclizumab High-Yield Process) For Treatment of MS
Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis?
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
Multiple sclerosis and vitamin D during pregnancy and lactation.
Molecular cloning of a human cannabinoid receptor which is also expressed in testis.
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis.
Imaging of the spine at 3 tesla.
Value of NMO-IgG determination at the time of presentation as CIS.
Response to disease modifying therapies in African Americans with multiple sclerosis.
[Anti-NMDA receptor encephalitis - case report].
Dimethyl fumarate - only an anti-psoriatic medication?
Review of MR elastography applications and recent developments.
Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.
G protein-coupled receptor 30 contributes to improved remyelination after cuprizone-induced demyelination.
Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
Continuous prediction of secondary progression in the individual course of multiple sclerosis.
Exploring brainstem function in multiple sclerosis by combining brainstem reflexes, evoked potentials, clinical and MRI investigations.
Deaths and disability from natalizumab are no longer tolerable: No - (they can be avoided).
A population based cohort study to assess the safety of pandemic influenza vaccine Focetria(®) in Emilia-Romagna region, Italy-Part Two.
The Ex Vivo Production of IL-6 and IL-21 by CD4(+) T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients.
Structural connectomics in brain diseases.
Sustained-Release Fampridine (4-Aminopyridine) in Multiple Sclerosis: Efficacy and Impact on Motor Function.
Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study.
Pages
« first
‹ previous
…
216
217
218
219
220
221
222
223
224
…
next ›
last »